Heart HealthResearch PaperPaywall

Light-powered nanorobots make ATP inside injured heart cells and restore mitochondrial function

Near-infrared light drives nanorobots to synthesize ATP inside damaged cardiomyocytes, easing mitochondrial stress in a preclinical heart-injury study.

Saturday, November 21, 2026 0 views
Published in Sci Adv
Laboratory microscope view of cultured heart muscle cells beside a near-infrared lamp and a researcher's pipette

Summary

Injured heart muscle cells lose their ability to make energy, and that failure drives much of the damage after a heart attack. Injecting ATP, the cell's energy currency, has not worked well because it cannot be delivered into the right cells. Researchers built tiny self-propelled particles, called nanorobots, that carry ATP-making molecular motors. When lit with near-infrared light, the motors spin, pushing the particles forward and producing ATP. The particles enter heart cells, escape their internal compartments, and penetrate injured heart tissue. Inside the cells, the added ATP rebalanced the NAD+/NADH ratio, reduced abnormal opening of a mitochondrial pore (mPTP), and lowered calcium overload. The authors report restored mitochondrial integrity and better heart muscle recovery. This is preclinical work, and this summary rests on the abstract alone. The model species, group sizes, and the size of the functional benefit are not stated there. Human safety and effect have not been shown.

Detailed Summary

Heart injury is a leading cause of death worldwide, and its core feature is a collapse of mitochondrial energy production in cardiomyocytes. Because heart function declines and injury risk rises with age, restoring cellular energy is an appealing repair strategy. Clinical ATP injections have had limited efficacy because the ATP cannot be delivered in situ, inside the cells that need it.

The researchers built Janus nanorobots, particles with two distinct faces, made by mechanical extrusion-assisted phase separation. They asymmetrically integrate chromatophore-coupled FoF1-ATP synthases, the rotary enzymes that make ATP. Under structured near-infrared light, the enzymes rotate in a coordinated way. That rotation both propels the particles and catalyzes high-yield ATP synthesis.

Per the abstract, the nanorobots were internalized by cardiomyocytes, escaped lysosomes, and penetrated deeply into injured myocardial tissue. Inside the cells, locally raised ATP rebalanced the NAD+/NADH ratio, suppressed pathological opening of the mitochondrial permeability transition pore, and reduced calcium overload. The authors conclude that these changes together restored mitochondrial integrity and promoted functional myocardial recovery. These are mechanism and function readouts. The abstract reports no lifespan or survival outcome.

The implication is a proof of concept for delivering bioenergy directly into damaged cells, rather than supplying ATP externally. It targets mitochondrial failure, a shared feature of ischemic injury and energy-deficient cardiomyopathies, and it links to NAD+ redox balance and calcium handling, which matter in cardiac aging.

Caveats are substantial. Only the abstract was available, so the species, model, sample sizes, effect sizes, dosing, and safety data are unknown. Near-infrared light penetrates tissue poorly, which raises questions about activating the particles in a human heart. Immune response, clearance, and long-term effects are not described. No human data are reported, so the finding is a mechanism worth watching, not a therapy.

Key Findings

  • Light-driven nanorobots with FoF1-ATP synthase made ATP inside cardiomyocytes, targeting the energy deficit of injured heart cells.
  • Particles entered cells, escaped lysosomes, and penetrated injured myocardial tissue, per the abstract.
  • Mechanism: raised ATP rebalanced NAD+/NADH, suppressed mPTP opening, and reduced calcium overload.
  • Function: authors report restored mitochondrial integrity and functional myocardial recovery; effect sizes are not given in the abstract.
  • No lifespan or human outcome is reported; model species and sample size are unstated in the abstract.

Methodology

This is a preclinical engineering and biology study of Janus nanorobots built by mechanical extrusion-assisted phase separation with chromatophore-coupled FoF1-ATP synthases, activated by structured near-infrared light. The abstract describes cell uptake, lysosomal escape, tissue penetration, and mitochondrial readouts. The species, injury model, group sizes, controls, and statistics are not given in the abstract.

Study Limitations

This summary is based on the abstract only, so design details, effect sizes, and any adverse findings are unavailable. Near-infrared light's limited tissue penetration, nanoparticle safety, immune response, and clearance are not addressed in the abstract. No human data or lifespan outcomes are reported.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: